Francisco J. Cimas

University of Castilla-La Mancha

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Sonia Castillo‐Lluva

SPAIN

View details

Guillermo Velasco

Associate Professor (Profesor Titular)

Universidad Complutense de Madrid

SPAIN

View details

Mariona Baliu-Piqué

Head

SPAIN

View details

Antonio Fernandez Aramburo

PROFESOR ASOCIADO

Universidad de Murcia Facultad de Medicina

SPAIN

View details

Angel L. Corbí

Head of Myeloid Cell Laboratory

Consejo Superior de Investigaciones Cientificas

SPAIN

View details

Ricardo Sanchez-Prieto

profesor asociado

University of Castilla-La Mancha

SPAIN

View details

Dr. José A. Castro-Osma

Profesor Contratado Doctor Interino

Universidad de Castilla-La Mancha - Campus de Albacete

SPAIN

View details

María José Ruiz Hidalgo

Profesor Titular de Universidad

University of Castilla-La Mancha

SPAIN

View details

MARIA DEL MAR;MARIA DEL MAR LORENTE PEREZ;LORENTE PEREZ

Universidad Complutense de Madrid

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francisco J. Cimas

Research Interests

Explore related searches

Contact this professor

Articles (11)

P38 MAPK and Radiotherapy: Foes or Friends?

The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer

Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

The Gene Signature of Activated M-CSF-Primed Human Monocyte-Derived Macrophages Is IL-10-Dependent

Transcriptomic Correlates of Immunologic Activation in Head and Neck and Cervical Cancer

Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.

In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer.

10P Genomic profiles of CD47 in breast tumours predict outcome and are associated with immune activation and enrichment of pro-tumoral macrophage markers

Controlled Delivery of BET-PROTACs: In Vitro Evaluation of MZ1-Loaded Polymeric Antibody Conjugated Nanoparticles in Breast Cancer.

91P Transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer

An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy.

Collaborators (9)

Sonia Castillo‐Lluva

Guillermo Velasco

Mariona Baliu-Piqué

Antonio Fernandez Aramburo

Angel L. Corbí

Ricardo Sanchez-Prieto

Dr. José A. Castro-Osma

María José Ruiz Hidalgo

MARIA DEL MAR;MARIA DEL MAR LORENTE PEREZ;LORENTE PEREZ

Make your next move.